{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:02:52Z","timestamp":1793865772552,"version":"4.6.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Infection is a leading cause of mortality in idiopathic inflammatory myopathies (IIMs). This study aimed to develop a nomogram for predicting severe infection risk in IIM patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with IIMs admitted to Zhongshan Hospital, Fudan University, from January 2015 to January 2022 were enrolled. They were randomly divided into derivation (70%) and validation (30%) sets. Univariate and multivariate Cox regression identified independent risk factors for severe infection, and the Akaike information criterion (AIC) was applied for model selection. A nomogram was constructed to predict severe infection risks at 6 months, 1 year, and 3 years. Predictive accuracy and discriminative ability were evaluated using the concordance index (C-index), calibration curves, and the area under the receiver operating characteristic curve (AUC). Decision curve analysis (DCA) assessed clinical utility. Kaplan-Meier (K-M) curves were used to analyze survival differences between high- and low-risk groups stratified by nomogram scores.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 263 IIM patients, 81 experienced 106 severe infection events, with lower respiratory tract infections being the most common (47.2%). Independent risk factors included age at onset (HR 1.024, 95% CI 1.002-1.046, <jats:italic>p<\/jats:italic>=0.036), lactate dehydrogenase (HR 1.002, 95% CI 0.999-1.005, <jats:italic>p<\/jats:italic>=0.078), HRCT score (HR 1.004, 95% CI 1.001-1.006, <jats:italic>p<\/jats:italic>=0.002), and lymphocyte count (HR 0.48, 95% CI 0.23-0.99, <jats:italic>p<\/jats:italic>=0.048). The nomogram demonstrated strong predictive performance, with AUCs of 0.84, 0.83, and 0.78 for 6 months, 1 year, and 3 years in the derivation set, and 0.91, 0.77, and 0.64 in the validation set. Calibration curves showed good agreement between predicted and observed risks, while DCA demonstrated significant net benefit over individual predictors. Kaplan-Meier curves revealed significant differences in the cumulative risk of severe infection between high- and low-risk groups. Further validation in DM and ASS subgroups demonstrated that the nomogram effectively predicted severe infections, with AUCs of 0.86, 0.81, and 0.73 for DM and 0.86, 0.83, and 0.74 for ASS at 6 months, 1 year, and 3 years, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We have developed a new nomogram to predict severe infection risk in IIM patients at 6 months, 1 year, and 3 years. This model aids clinicians and patients in formulating treatment and follow-up strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1471152","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T12:23:37Z","timestamp":1741177417000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of a nomogram for predicting the incidence of infectious events in patients with idiopathic inflammatory myopathies"],"prefix":"10.3389","volume":"16","author":[{"given":"Luwei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongfei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-98818-6.00023-6","article-title":"Autoimmune inflammatory myopathies","volume":"195","author":"Dalakas","year":"2023","journal-title":"Handb Clin Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41584-023-01033-0","article-title":"Epidemiology of the idiopathic inflammatory myopathies","volume":"19","author":"Khoo","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211402","article-title":"Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study","volume":"77","author":"Dobloug","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/0ddt88","article-title":"Nomogram to predict dermatomyositis prognosis: a population-based study of 457 cases","volume":"40","author":"Li","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-023-01790-w","article-title":"Risk of early infection in idiopathic inflammatory myopathies: cluster analysis based on clinical features and biomarkers","volume":"46","author":"Cheng","year":"2023","journal-title":"Inflammation"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22501","article-title":"A population-based study of infection-related hospital mortality in patients with dermatomyositis\/polymyositis","volume":"67","author":"Murray","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semarthrit.2010.08.003","article-title":"Infectious complications in polymyositis and dermatomyositis: a series of 279 patients","volume":"41","author":"Marie","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/yps7ai","article-title":"Infection is not rare in patients with idiopathic inflammatory myopathies","volume":"40","author":"Ge","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscular disorders: NMD"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/art.42308","article-title":"Identification of three different phenotypes in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis patients: implications for prediction of rapidly progressive interstitial lung disease","volume":"75","author":"Xu","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/00005382-199623000-00002","article-title":"High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis","volume":"11","author":"Ikezoe","year":"1996","journal-title":"J Thorac Imaging"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq279","article-title":"Infections in polymyositis and dermatomyositis: analysis of 192 cases","volume":"49","author":"Chen","year":"2010","journal-title":"Rheumatol (Oxford England)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2011.1280","article-title":"Relationship between cytomegalovirus reactivation and dermatomyositis","volume":"21","author":"Kanetaka","year":"2011","journal-title":"Eur J Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.740154","article-title":"Association of cytomegalovirus infection with anti-MDA5 antibody-positive dermatomyositis: A prospective cohort study","volume":"8","author":"Huang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15274","article-title":"Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis","volume":"47","author":"Matsuda","year":"2020","journal-title":"J Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3877\/cma.j.issn.1674-0785.2016.13.014","article-title":"Clinical analysis of dermatomyositis associated with human IgM cytomegalovirus","volume":"10","author":"Zhao","year":"2016","journal-title":"Chin J Clin (Electronic Edition)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0441-9","article-title":"Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review","volume":"26","author":"Falagas","year":"2007","journal-title":"Clin Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1186\/s12879-021-06374-3","article-title":"Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study","volume":"21","author":"Yamashita","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/imj.2014.44.issue-12b","article-title":"Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid Malignancies, 2014","volume":"44","author":"Cooley","year":"2014","journal-title":"Intern Med J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/mus.28114","article-title":"Management of immune-mediated necrotizing myopathy","volume":"70","author":"Suh","year":"2024","journal-title":"Muscle Nerve"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-024-01337-y","article-title":"Immune-mediated necrotizing myopathies: current landscape","volume":"24","author":"Koumas","year":"2024","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/art.21083","article-title":"Opportunistic infections in polymyositis and dermatomyositis","volume":"53","author":"Marie","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.152","article-title":"Incidence, risk factors, and severity of herpesvirus infections in a cohort of 121 patients with primary dermatomyositis and dermatomyositis associated with a Malignant neoplasm","volume":"145","author":"Fardet","year":"2009","journal-title":"Arch Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1471152\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T12:23:41Z","timestamp":1741177421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1471152\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":25,"alternative-id":["10.3389\/fimmu.2025.1471152"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1471152","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"article-number":"1471152"}}